DXB 2.38% 43.0¢ dimerix limited

Ann: Dimerix Completes $20M Placement, page-88

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 543 Posts.
    lightbulb Created with Sketch. 240
    So? This has nothing to do with that.
    —-what I’m referring to is where in the treatment guidelines or practices this dimx drug will fit because there are a number of immunological drugs already used first line (check this out
    https://kdigo.org/wp-content/uploads/2022/12/How-I-Treat-FSGS.pdf

    —- this dimx drug looks a comparatively weaker immunological drug compared with the powerful drugs already used, I don’t see it replacing established things referenced in the article like steroids or calcineurim inhib, rituximab.
    —— dimx drug looks like it’s v safe, but lack of side effects is probably an indication of its weaker immunological ability.
    —-/ looks more like a back up reserve drug to use once you’ve exhausted other things
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.